Note sull'episodio
Rheumatologist Joerg Ermann, MD, discusses biosimilars and how they are similar to biologics in the treatment of spondyloarthritis.
Parole chiave
biosimilarsafety
Rheumatologist Joerg Ermann, MD, discusses biosimilars and how they are similar to biologics in the treatment of spondyloarthritis.